Tositumomab

Tositumomab is a monoclonal antibody that binds to CD20 antigen, and can be labeled with idodine-131 to yield 131I-labelled tositumomab (Bexxar®, Corixa and GlaxoSmithKline, Seattle, WA, USA) (10). The activity of 131I-tositumomab depends on several mechanisms, including ionizing radiation from 1311. It has been approved by the U.S. FDA for the treatment of patients with CD20 antigen-positive relapsed or refractory, low-grade, follicular or transformed lymphomas including rituximab-refractory lymphoma (10). The influence of polymorphisms on clinical outcomes following Bexxar therapy has not been investigated.

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment